Foundry Partners’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-16,146
| Closed | -$1.5M | – | 393 |
|
|
2021
Q1 | $1.5M | Sell |
16,146
-2,303
| -12% | -$214K | 0.05% | 318 |
|
|
2020
Q4 | $1.65M | Sell |
18,449
-82
| -0.4% | -$7.35K | 0.06% | 302 |
|
|
2020
Q3 | $1.92M | Sell |
18,531
-77,203
| -81% | -$7.98M | 0.09% | 254 |
|
|
2020
Q2 | $7.57M | Buy |
95,734
+67,025
| +233% | +$5.3M | 0.37% | 99 |
|
|
2020
Q1 | $1.66M | Sell |
28,709
-20,162
| -41% | -$1.17M | 0.09% | 242 |
|
|
2019
Q4 | $2.64M | Sell |
48,871
-1,163
| -2% | -$62.8K | 0.1% | 236 |
|
|
2019
Q3 | $2.62M | Sell |
50,034
-489
| -1% | -$25.6K | 0.11% | 232 |
|
|
2019
Q2 | $2.44M | Sell |
50,523
-151
| -0.3% | -$7.3K | 0.1% | 240 |
|
|
2019
Q1 | $2.56M | Sell |
50,674
-3,109
| -6% | -$157K | 0.1% | 248 |
|
|
2018
Q4 | $3.19M | Buy |
53,783
+387
| +0.7% | +$22.9K | 0.14% | 214 |
|
|
2018
Q3 | $3.52M | Sell |
53,396
-81
| -0.2% | -$5.33K | 0.13% | 232 |
|
|
2018
Q2 | $2.7M | Sell |
53,477
-3,283
| -6% | -$166K | 0.11% | 250 |
|
|
2018
Q1 | $2.99M | Sell |
56,760
-266
| -0.5% | -$14K | 0.13% | 238 |
|
|
2017
Q4 | $2.65M | Sell |
57,026
-44,496
| -44% | -$2.07M | 0.11% | 239 |
|
|
2017
Q3 | $4.11M | Buy |
101,522
+10,014
| +11% | +$405K | 0.16% | 220 |
|
|
2017
Q2 | $3.1M | Sell |
91,508
-5,262
| -5% | -$178K | 0.13% | 261 |
|
|
2017
Q1 | $2.81M | Sell |
96,770
-212
| -0.2% | -$6.16K | 0.12% | 273 |
|
|
2016
Q4 | $3.19M | Buy |
+96,982
| New | +$3.19M | 0.14% | 252 |
|